Literature DB >> 17299817

Synthesis, characterization, and antioxidant activity of some ebselen analogues.

Krishna P Bhabak1, Govindasamy Mugesh.   

Abstract

Simple synthetic routes for several analogues of the anti-inflammatory organoselenium drug, ebselen, are described. The compounds are characterized by (1)H, (13)C, and (77)Se NMR spectroscopy and mass spectral techniques and, in some cases, by single-crystal X-ray diffraction studies. The glutathione peroxidase (GPx)-like antioxidant activity has been studied by using H(2)O(2), tBuOOH, and Cum-OOH as substrates, and thiophenol (PhSH, 4-Me-C(6)H(4)SH) and glutathione (GSH) as cosubstrates. Density functional theory (DFT) calculations have been performed on these systems to understand the effects of various substituents on the (77)Se NMR chemical shifts; these results have been compared with the experimental data. The experimental and theoretical results suggest that the presence of a phenyl substituent on the nitrogen atom is important for the antioxidant activity of ebselen. While ebselen and its analogues are poor catalysts in aromatic thiol assays, these compounds exhibit high GPx activity when GSH is used as the cosubstrate. The poor catalytic activity of ebselen analogues in the presence of aromatic thiols such as PhSH and 4-Me-C(6)H(4)SH can be ascribed to the undesired thiol exchange reaction that takes place at the selenium center due to SeO nonbonding interactions. To understand the effects of different peroxides on the catalytic activities, we have determined the initial rates at various concentrations of GSH and peroxides. These data suggest that the nature of peroxide has little effect on the catalytic efficiencies, although the initial reaction rates observed with hydrogen peroxide were found to be higher than that with tBuOOH and Cum-OOH. In contrast to the effect of peroxides, the nature of thiols appears to have a dramatic effect on the catalytic activity of ebselen and its related derivatives.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299817     DOI: 10.1002/chem.200601584

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  15 in total

1.  Evaluation of the neurotoxic/neuroprotective role of organoselenides using differentiated human neuroblastoma SH-SY5Y cell line challenged with 6-hydroxydopamine.

Authors:  Fernanda Martins Lopes; Giovana Ferreira Londero; Liana Marengo de Medeiros; Leonardo Lisbôa da Motta; Guilherme Antônio Behr; Valeska Aguiar de Oliveira; Mohammad Ibrahim; José Cláudio Fonseca Moreira; Lisiane de Oliveira Porciúncula; João Batista Teixeira da Rocha; Fábio Klamt
Journal:  Neurotox Res       Date:  2012-01-20       Impact factor: 3.911

2.  High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S).

Authors:  Brice A P Wilson; Haofan Wang; Benjamin A Nacev; Ronnie C Mease; Jun O Liu; Martin G Pomper; William B Isaacs
Journal:  Mol Cancer Ther       Date:  2011-03-25       Impact factor: 6.261

3.  Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse.

Authors:  Phyllis Chew; Derek Y C Yuen; Nada Stefanovic; Josefa Pete; Melinda T Coughlan; Karin A Jandeleit-Dahm; Merlin C Thomas; Franklin Rosenfeldt; Mark E Cooper; Judy B de Haan
Journal:  Diabetes       Date:  2010-09-07       Impact factor: 9.461

Review 4.  Applications of heteronuclear NMR spectroscopy in biological and medicinal inorganic chemistry.

Authors:  Luca Ronconi; Peter J Sadler
Journal:  Coord Chem Rev       Date:  2008-01-26       Impact factor: 22.315

5.  (7aR*,12bS*)-8,12b-Dihydro-7aH-indeno-[1',2':5,6][1,4]selenazino[2,3,4-ij]quinolin-13-ium hydrogen sulfate.

Authors:  Gunay Z Mammadova; Zhanna V Matsulevich; Galina N Borisova; Alexander V Borisov; Victor N Khrustalev
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-11-12

6.  Convergent Synthesis of Two Fluorescent Ebselen-Coumarin Heterodimers.

Authors:  Jim Küppers; Anna Christina Schulz-Fincke; Jerzy Palus; Mirosław Giurg; Jacek Skarżewski; Michael Gütschow
Journal:  Pharmaceuticals (Basel)       Date:  2016-07-08

7.  N-(2-Methyl-phen-yl)-1,2-benzoselen-azol-3(2H)-one.

Authors:  Xu Zhu; Ying Xu; Hongfei Han; Zhiqiang Guo; Xuehong Wei
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-09-12

Review 8.  Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease.

Authors:  Sushruta Koppula; Hemant Kumar; Sandeep Vasant More; Byung Wook Kim; In Su Kim; Dong-Kug Choi
Journal:  Int J Mol Sci       Date:  2012-08-23       Impact factor: 6.208

9.  The modified selenenyl amide, M-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout mice.

Authors:  Sih Min Tan; Arpeeta Sharma; Derek Y C Yuen; Nada Stefanovic; Guy Krippner; Govindasamy Mugesh; Zhonglin Chai; Judy B de Haan
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

10.  Evaluation of ebselen supplementation on cryopreservation medium in human semen.

Authors:  Zohreh Khodayari Naeini; Hassan Hassani Bafrani; Hossein Nikzad
Journal:  Iran J Reprod Med       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.